Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
1(6%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
6%
Ph phase_3
5
29%
Ph phase_2
2
12%
Ph phase_4
4
24%
Ph not_applicable
5
29%

Phase Distribution

1

Early Stage

2

Mid Stage

9

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
1(5.9%)
Phase 2Efficacy & side effects
2(11.8%)
Phase 3Large-scale testing
5(29.4%)
Phase 4Post-market surveillance
4(23.5%)
N/ANon-phased studies
5(29.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

17

all time

Status Distribution
Active(2)
Completed(10)
Other(5)

Detailed Status

Completed10
unknown5
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.9%)
Phase 22 (11.8%)
Phase 35 (29.4%)
Phase 44 (23.5%)
N/A5 (29.4%)

Trials by Status

unknown529%
not_yet_recruiting16%
completed1059%
recruiting16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07449689Phase 4

Comparing Acotiamide and Itopride for the Management of Indigestion

Not Yet Recruiting
NCT05966025Phase 2

Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)

Unknown
NCT05134584Phase 4

Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders

Unknown
NCT04104867Not Applicable

Effectiveness of Prokinetic Agents in Improving Abdominal Discomfort at Colonoscopy

Unknown
NCT04697641Not Applicable

Helicobacter Pylori Eradication in Functional Dyspepsia

Completed
NCT04647955Phase 4

Functional Dyspepsia: Validation of a Questionnaire for Symptom Assessment in FD PDS Subgroup

Completed
NCT04464369Phase 4

Functional Dyspepsia: Validation of the Leuven Postprandial Distress Scale (LPDS) in a Placebo-controlled Trial

Completed
NCT04161768Phase 3

Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Recruiting
NCT03698292Not Applicable

Itopride in Feeding Intolerance of Critically-ill Patients Receiving Enteral Nutrition

Unknown
NCT00370084Phase 1

Itopride Hydrochloride in Diabetes: Effects on Gastric Emptying and Glycemia

Completed
NCT00382577Phase 3

Efficacy and Safety of Itopride vs Placebo in Heartburn

Completed
NCT00112203Phase 3

Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia

Completed
NCT00112190Phase 3

Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal

Completed
NCT01513096Phase 3

Efficacy of Prokinetics With Split Dose of PEG in Morning Colonoscopic Bowel Preparation

Completed
NCT00599677Not Applicable

Randomized Controlled Trial of Acupuncture for Functional Dyspepsia

Completed
NCT00308399Phase 2

A Study to Evaluate the Effect of a Medicine on Gastric Functions in Healthy Volunteers.

Completed
NCT01226134Not Applicable

Effect Of Itopride On Gastric Emptying And Accommodation In Patients With Functional Dyspepsia

Unknown

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17